# Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management

> **NCT02608177** · NA · COMPLETED · sponsor: **University of Washington** · enrollment: 3 (actual)

## Conditions studied

- Chronic Kidney Diseases
- Type 2 Diabetes

## Interventions

- **DRUG:** Linagliptin
- **DRUG:** Glipizide

## Key facts

- **NCT ID:** NCT02608177
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2017-08
- **Final completion:** 2018-08
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2018-10-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02608177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02608177, "Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02608177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*